| Adventhealth Care Center Apopka South | |
| 3355 E Semoran Blvd, Apopka, Florida 32703 | |
| (407) 862-6263 | |
| Name | Adventhealth Care Center Apopka South |
|---|---|
| Location | 3355 E Semoran Blvd, Apopka, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 222 |
| Occupancy Rate | 65.72% |
| Medicare ID (CCN) | 105353 |
| Legal Business Name | Flnc Inc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1013134287 |
| Organization Name | SHCC SERVICES INC |
| Doing Business As | FLORIDA LIVING NURSING CENTER |
| Address | 3355 E Semoran Blvd, Apopka, FL 32703 |
| Phone Number | 407-862-6263 |
News Archive
The differences in the male and female immune responses, which make females more prone to autoimmune disease and males more subject to infections, are established during puberty.
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced its intention to complete the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, for all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc., upon its currently scheduled expiration at 12:00 midnight, New York City time, on June 30, 2010 (the end of the day on June 30, 2010).
Eisai Inc. announced today the results of its Phase 3 trial (Study 309), which showed that eribulin met the study's primary endpoint evaluating overall survival in patients who had advanced leiomyosarcoma (LMS) or adipocytic sarcoma (ADI), two types of advanced soft tissue sarcoma.
Access Scientific, Inc. today announced it has received FDA 510(k) clearance for the POWERWAND — an extended-dwell, power-injectable 3.1 inch IV catheter delivered by means of The WAND's proprietary Accelerated Seldinger Technique.
› Verified 8 days ago
| NPI Number | 1942909908 |
| Organization Name | APOPKA SOUTH SNF OPERATIONS LLC |
| Address | 3355 E Semoran Blvd, Apopka, FL 32703 |
| Phone Number | 407-862-6263 |
News Archive
The differences in the male and female immune responses, which make females more prone to autoimmune disease and males more subject to infections, are established during puberty.
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced its intention to complete the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, for all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc., upon its currently scheduled expiration at 12:00 midnight, New York City time, on June 30, 2010 (the end of the day on June 30, 2010).
Eisai Inc. announced today the results of its Phase 3 trial (Study 309), which showed that eribulin met the study's primary endpoint evaluating overall survival in patients who had advanced leiomyosarcoma (LMS) or adipocytic sarcoma (ADI), two types of advanced soft tissue sarcoma.
Access Scientific, Inc. today announced it has received FDA 510(k) clearance for the POWERWAND — an extended-dwell, power-injectable 3.1 inch IV catheter delivered by means of The WAND's proprietary Accelerated Seldinger Technique.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The differences in the male and female immune responses, which make females more prone to autoimmune disease and males more subject to infections, are established during puberty.
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced its intention to complete the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, for all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc., upon its currently scheduled expiration at 12:00 midnight, New York City time, on June 30, 2010 (the end of the day on June 30, 2010).
Eisai Inc. announced today the results of its Phase 3 trial (Study 309), which showed that eribulin met the study's primary endpoint evaluating overall survival in patients who had advanced leiomyosarcoma (LMS) or adipocytic sarcoma (ADI), two types of advanced soft tissue sarcoma.
Access Scientific, Inc. today announced it has received FDA 510(k) clearance for the POWERWAND — an extended-dwell, power-injectable 3.1 inch IV catheter delivered by means of The WAND's proprietary Accelerated Seldinger Technique.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $182093 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16.03 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.03 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 64.04 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.9 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.66 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.79 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 95.62 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.32 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 81.79 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.65 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 30.33 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 25.86 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 14.25 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 93.79 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 70.72 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 82.63 | 82.93 |
News Archive
The differences in the male and female immune responses, which make females more prone to autoimmune disease and males more subject to infections, are established during puberty.
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced its intention to complete the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, for all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc., upon its currently scheduled expiration at 12:00 midnight, New York City time, on June 30, 2010 (the end of the day on June 30, 2010).
Eisai Inc. announced today the results of its Phase 3 trial (Study 309), which showed that eribulin met the study's primary endpoint evaluating overall survival in patients who had advanced leiomyosarcoma (LMS) or adipocytic sarcoma (ADI), two types of advanced soft tissue sarcoma.
Access Scientific, Inc. today announced it has received FDA 510(k) clearance for the POWERWAND — an extended-dwell, power-injectable 3.1 inch IV catheter delivered by means of The WAND's proprietary Accelerated Seldinger Technique.
› Verified 8 days ago
Adventhealth Care Center Apopka South Location: 3355 E Semoran Blvd, Apopka, Florida 32703 Phone: (407) 862-6263 | |
Adventhealth Care Center Apopka North Location: 305 East Oak Street, Apopka, Florida 32703 Phone: (407) 880-2266 | |
Apopka Health And Rehabilitation Center Location: 2001 Alston Bay Blvd, Apopka, Florida 32703 Phone: (407) 565-5990 |